Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
RION CoRIOXF 90 EV-to-EBITDA is 5.75 as of Jul. 26, 2026, which is 25% below its 10-year median of 7.65. GuruFocus rates RIOXF with a GF Score™ of 90/100 and a GF Value™ of $11.60. The stock has 1 warning sign investors should review. Among 511 Medical Devices & Instruments companies, RION Co ranks better than 84.15% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, RION Co's enterprise value is $217.6 Mil.
RION Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $37.8 Mil. Therefore, RION Co's EV-to-EBITDA for today is 5.75.
The historical rank and industry rank for RION Co's EV-to-EBITDA or its related term are showing as below:
RIOXF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.55 Med: 7.65 Max: 16.21
Current: 6.17
During the past 13 years, the highest EV-to-EBITDA of RION Co was 16.21. The lowest was 3.55. And the median was 7.65.
RIOXF's EV-to-EBITDA is ranked better than 84.15% of 511
companies
in the Medical Devices & Instruments industry
Industry Median: 14.03
vs RIOXF: 6.17
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
RION Co (OTCPK:RIOXF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
RION Co's share price for today is $14.63.
RION Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.533.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for RION Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, RION Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RION Co EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, RION Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where RION Co's EV-to-EBITDA falls into.
RION Co's current Enterprise Value is $217.6 Mil.
RION Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $37.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RION Co (RIOXF) has a EV-to-EBITDA of 5.75 as of Jul. 26, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on RION Co. This is 25% below median its historical median of 7.65. Over the past decade, RION Co's EV-to-EBITDA has ranged from 3.55 to 16.21. According to the industry distribution chart, RION Co ranks #81 out of 511 companies in the Medical Devices & Instruments industry, placing it in the top 15.9%.
Is RION Co's EV-to-EBITDA too high?
RION Co's current EV-to-EBITDA of 5.75 is 25% below median its 10-year median of 7.65. Over the past 10 years, this metric has ranged from a low of 3.55 to a high of 16.21. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.03. RION Co's value of 5.75 is 59% below this industry median. Based on the distribution chart, RION Co ranks #81 out of 511 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, RION Co has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does RION Co's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, RION Co ranks #81 out of 511 companies for EV-to-EBITDA. This places RION Co in the top 16% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 14.03. RION Co's value of 5.75 is 59% below this benchmark. Historically, RION Co's own EV-to-EBITDA has ranged from 3.55 to 16.21 over the past decade. While the company's 10-year median is 7.65 vs. the industry median of 14.03, RION Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.03, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RION Co's current EV-to-EBITDA of 5.75 is 59% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on RION Co. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RION Co's current EV-to-EBITDA is 5.75, which is 25% below median its own 10-year median of 7.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RION Co stock overvalued right now?
RION Co (RIOXF) has a current EV-to-EBITDA of 5.75. The stock's GF Value™ is $11.60, compared to a current price of $14.63 — trading 26.1% above its estimated fair value. The current EV-to-EBITDA is 5.75, which is 25% below median its 10-year median of 7.65 and 59% below the Medical Devices & Instruments industry median of 14.03. RION Co's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For RION Co (RIOXF), the current EV-to-EBITDA is 5.75 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RION Co (RIOXF) Overvalued in 2026?
Based on GuruFocus' analysis, RION Co stock appears to be overvalued.
The current stock price of $14.63 is trading 26.1% above its estimated GF Value™ of $11.60.
Key valuation signals for RIOXF:
EV-to-EBITDA: 5.75 (25% below median its 10-year median of 7.65)
GF Value™: $11.60 vs. price of $14.63 (26.1% above fair value)
Industry Position: 59% below the Medical Devices & Instruments median (#81 of 511)
No single metric tells the full story. See the RIOXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RION Co Ltd is engaged in manufacturing and selling of maintenance services of a medical device. The company offers hearing instruments and medical equipment, an environmental device including sound and vibration measuring instruments and particle counters and parts and equipment.
90GF Score
Get the complete analysis for RIOXF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RIOXF has been successfully added to your 
